bat
host
virul
zoonot
virus
without
experienc
diseas
mechanist
understand
impact
bat
viru
host
capac
includ
uniqu
constitut
immun
pathway
cellularscal
viral
dynam
need
elucid
zoonot
emerg
carri
viru
infect
assay
bat
cell
line
express
induc
constitut
immun
phenotyp
develop
theoret
model
vitro
system
fit
empir
data
best
fit
model
recapitul
expect
immun
phenotyp
repres
cell
line
support
robust
antivir
defens
bat
cell
correl
higher
estim
withinhost
viral
propag
rate
gener
heighten
immun
respons
limit
pathogeninduc
cellular
morbid
facilit
establish
rapidlypropag
persist
infect
withinhost
rapidlyrepl
virus
evolv
bat
immun
system
like
caus
enhanc
virul
follow
emerg
secondari
host
immun
system
diverg
uniqu
bat
ccbi
intern
licens
made
avail
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
recent
research
advanc
begin
shed
light
molecular
mechan
bat
avoid
patholog
otherwis
virul
pathogen
brook
dobson
bat
leverag
suit
speciesspecif
mechan
limit
viral
load
includ
host
receptor
sequenc
incompat
batviru
combin
ng
et
al
igarashi
et
al
constitut
express
antivir
cytokin
ifn
other
zhou
et
al
typic
presenc
viral
rna
dna
cytoplasm
mammalian
cell
induc
secret
type
interferon
protein
ifnand
ifn
promot
express
translat
interferonstimul
gene
isg
neighbor
cell
render
effect
antivir
stetson
medzhitov
bat
cell
transcriptom
blueprint
ifn
respons
express
constitut
even
absenc
stimul
viral
rna
dna
zhou
et
al
nonfli
mammal
constitut
ifn
express
would
like
elicit
widespread
inflamm
concomit
immunopatholog
upon
viral
infect
bat
defin
induc
immun
complet
model
cell
suscept
viral
invas
diseas
free
equilibrium
defens
induc
subsequ
viral
exposur
term
contrast
allow
extent
constitut
immun
vari
across
paramet
rang
defin
constitut
system
one
contain
antivir
cell
diseas
free
equilibrium
fit
model
tissu
cultur
data
independ
estim
well
celltocel
transmiss
rate
cellviru
combin
pathogen
invad
host
tissu
cultur
rapid
rate
constitut
antivir
acquisit
drive
tissu
cultur
highli
constitut
antivir
immun
therefor
resist
viru
invas
outset
sinc
definit
induc
immun
stimul
follow
initi
viru
invas
rate
induc
antivir
acquisit
incorpor
equat
induc
immun
process
control
viru
initi
invas
prevent
occur
begin
case
fulli
induc
absent
immun
equat
thu
reduc
form
typic
classic
seir
model
know
constitut
antivir
cellreceptor
incompat
play
constitut
immun
assumpt
prohibit
pathogen
invas
model
fit
time
seri
constitut
assumpt
handicap
overestim
prohibit
pathogen
invas
incorpor
exceedingli
rapid
rate
induc
antivir
acquisit
could
model
guarante
initi
infect
would
permit
rapidli
control
fit
theoret
model
vitro
data
estim
withinhost
viru
transmiss
rate
rate
cellular
acquisit
antivir
statu
tabl
contrast
vero
cell
induc
immun
model
offer
best
fit
data
consist
report
pattern
literatur
valid
qpcr
tabl
infect
cell
line
recov
higher
estim
rvsvmarv
rvsvebov
revers
balanc
higher
estim
rate
acquisit
antivir
statu
rvsvebov
versu
rvsvmarv
gener
observ
rapid
rate
antivir
acquisit
either
induc
constitut
correl
higher
transmiss
rate
offset
valu
estim
infect
maintain
amplitud
estim
immuneabs
vero
cell
line
caus
gentler
epidem
reduc
cellular
mortal
figur
paramet
estim
local
region
correspond
endem
equilibrium
determinist
theoret
model
figur
yield
less
acut
epidem
nonetheless
went
extinct
stochast
experi
final
rvsvg
rvsvebov
trial
cell
best
fit
model
assum
constitut
immun
rvsvmarv
infect
match
equival
model
assum
either
induc
constitut
immunitywith
induc
model
favor
constitut
aic
comparison
one
fewer
paramet
estim
file
realiti
know
receptor
incompat
make
cell
line
constitut
refractori
rvsvmarv
infect
ng
chandran
cell
also
constitut
express
antivir
cytokin
ifn
model
fit
result
suggest
constitut
express
ifnmay
act
rapidli
induc
immun
respons
follow
viru
invas
constitut
secret
function
nonetheless
hypothes
cell
line
far
antivir
studywith
initi
antivir
rate
estim
sever
order
magnitud
higher
other
studi
either
induc
constitut
assumpt
found
r
essenti
unchang
across
differ
immun
assumpt
vero
cell
initi
antivir
rate
low
case
cell
high
initi
antivir
rate
either
induc
constitut
immun
result
correspondingli
high
estim
consequ
r
still
produc
epidem
curv
result
much
lower
estim
r
pair
absent
immun
find
suggest
antivir
immun
respons
protect
host
tissu
virusinduc
cell
mortal
may
facilit
establish
rapid
withinhost
transmiss
rate
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
final
protect
effect
antivir
cell
clearli
observ
spatial
confirm
result
simul
fit
time
seri
spatiallyexplicit
stochast
reconstruct
mean
field
model
spatial
simul
rate
antivir
acquisit
fix
fit
valu
deriv
mean
field
estim
transmiss
rate
fix
valu
ten
time
greater
estim
mean
field
condit
account
intensif
paramet
threshold
permit
pathogen
invas
local
spatial
interact
see
materi
method
video
figur
copyright
holder
preprint
peerreview
authorfund
experi
carri
three
immort
mammalian
kidney
cell
line
run
duplic
plate
typic
plate
three
virus
two
control
mock
well
two
well
two
well
except
plate
two
control
four
well
given
time
justifi
exempt
expect
ifnexpress
constitut
cell
ccbi
intern
licens
made
avail
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
assumpt
express
exhibit
lower
moi
also
present
higher
moi
gene
express
time
seri
four
plate
cell
lineviru
combin
incub
viru
one
hour
follow
incub
viru
aspir
cell
monolay
wash
pb
cover
agar
plaqu
assay
overlay
mimic
condit
infect
trial
run
plate
harvest
sequenti
timepoint
roughli
hour
postinfect
exact
time
vari
multipl
trial
run
simultan
upon
harvest
plate
agar
overlay
remov
viru
lyse
rna
extract
cell
use
zymo
quick
rna
mini
prep
kit
accord
manufactur
instruct
includ
step
cellular
dna
digest
postextract
rna
qualiti
verifi
via
nanodrop
rna
convert
cdna
use
invitrogen
superscript
iii
cdna
synthesi
kit
accord
manufactur
instruct
cdna
store
frozen
stock
await
qpcr
undertook
qpcr
cdna
assess
express
type
interferon
gene
ifn
housekeep
gene
actin
use
primer
previous
report
literatur
supplementari
file
qpcr
cdna
sampl
incub
deioniz
water
forwardrevers
primer
mix
itaq
univers
sybr
green
cycl
realtim
pcr
machin
follow
condit
initi
denatur
min
follow
cycl
denatur
sec
anneal
sec
extens
sec
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
three
cell
line
figur
supplement
yield
natur
mortal
rate
correspond
lifespan
approxim
hour
respect
vero
cell
line
figur
supplement
fix
viru
incub
rate
invers
shortest
observ
durat
time
initi
infect
observ
first
infecti
cell
via
fluoresc
microscop
nine
cell
line
viru
combin
rang
hour
fix
infectioninduc
mortal
rate
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
rewrot
equat
model
explicit
cell
densiti
within
defin
well
volum
note
two
system
equat
equival
paramet
valu
use
interchang
across
form
follow
system
n
indic
total
cell
capac
area
model
solv
adopt
next
gener
matrix
approach
heffernan
smith
wahl
appli
proport
system
equat
step
one
process
necessit
construct
two
transit
matric
f
matrix
describ
new
infect
creat
v
matrix
repres
host
transit
expos
infect
state
build
f
v
matric
first
calcul
valu
ps
diseas
free
equilibrium
dfe
wherebi
pi
pe
equal
zero
allow
presenc
antivir
cell
pa
diseas
free
equilibrium
though
equilibrium
quantiti
consequ
extent
constitut
immun
play
system
depend
certain
paramet
valu
pa
alway
diseas
free
equilibrium
allow
extent
constitut
immun
vari
paramet
valu
maintain
consist
publish
literatur
suggest
constitut
antivir
bat
cell
line
ie
interferonstimul
gene
isg
perpetu
express
like
ifn
precursor
other
still
requir
induct
upon
infect
dfe
antivir
popul
take
follow
form
extens
suscept
popul
repres
cell
either
absent
fulli
induc
immun
contract
ccbi
intern
licens
made
avail
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
neg
cell
proport
equilibrium
impos
follow
constraint
paramet
substitut
valu
ps
infecti
equat
find
f
matrix
take
follow
form
v
matrix
take
follow
form
best
fit
model
indic
daic
present
tabl
figur
main
text
lci
lower
uci
upper
confid
interv
confid
interv
shown
spatial
b
fix
time
estim
mean
mean
field
model
fit
pair
equival
valu
e
r
paramet
fix
follow
valu
mean
field
spatial
vero
consider
natur
variat
initi
cell
count
across
trial
result
subtl
differ
seed
densiti
growth
durat
time
trial
initi
well
subject
deem
reach
confluenc
baselin
cell
count
also
differ
across
three
cell
line
vari
substanti
natur
size
correct
variat
opt
model
proport
infecti
cell
space
per
hour
well
rather
reli
raw
count
data
end
collect
maximum
number
live
cell
count
suscept
control
well
timepoint
set
count
rough
measur
well
occup
cell
line
question
use
method
maximum
cell
count
respect
vero
cell
line
reflect
innat
variat
cell
size
convert
cell
count
tabul
via
imag
process
code
across
infecti
time
trial
proport
divid
count
total
number
possibl
cell
space
cell
line
question
though
clearli
subject
error
method
nonetheless
maintain
intern
consist
count
method
gener
reason
time
seri
origin
experi
directli
tabul
proport
infect
versu
uninfect
space
binari
imag
howev
approach
impair
abil
gener
across
less
dens
seed
trial
well
trial
cell
line
dispar
size
adopt
counttoproport
method
describ
gener
infecti
time
seri
evenli
distribut
time
step
fit
mean
field
mechanist
model
next
fit
seri
statist
model
proport
data
produc
imag
process
method
describ
gfpexpress
data
use
mgcv
packag
r
wood
fit
gener
addit
model
gam
gaussian
famili
time
elaps
hour
post
infect
predictor
variabl
proport
infecti
cell
respons
variabl
fit
separ
gam
model
uniqu
cell
viru
moi
combin
incorpor
random
effect
well
id
trial
model
individu
fix
smooth
paramet
trial
recommend
packag
author
wood
gampredict
function
use
return
estim
infecti
proport
per
hour
across
durat
time
seri
cellvirusmoi
combin
uninfect
count
hoechst
stain
data
much
less
numer
sinc
count
requir
termin
infect
trial
fixat
cell
definit
one
data
point
could
produc
per
trial
due
rel
scarciti
opt
fit
standard
linear
regress
model
gaussian
famili
data
rather
use
datahungri
gam
method
employ
set
time
elaps
post
infect
predictor
hoechst
stain
data
produc
uniqu
estim
proport
uninfect
cell
per
hour
across
durat
longestobserv
trial
random
effect
includ
model
result
time
seri
use
estim
natur
mortal
rate
cell
line
fit
control
well
data
depict
natur
suscept
declin
figur
supplement
ccbi
intern
licens
made
avail
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
